Cargando…
Risk of COVID-19 in Chagas Disease Patients: What Happen with Cardiac Affectations?
SIMPLE SUMMARY: The SARS-Cov-2 virus appeared as a pandemic at the end of 2019. Since then, the literature on the effects of this disease has been increasing. Chagas disease is more than 110 years old since its discovery, and the implications of these patients when co-infected with SARS-Cov-2 have n...
Autores principales: | Diaz-Hernandez, Alejandro, Gonzalez-Vazquez, Maria Cristina, Arce-Fonseca, Minerva, Rodriguez-Morales, Olivia, Cedilllo-Ramirez, Maria Lilia, Carabarin-Lima, Alejandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8148128/ https://www.ncbi.nlm.nih.gov/pubmed/34066383 http://dx.doi.org/10.3390/biology10050411 |
Ejemplares similares
-
Consensus Enolase of Trypanosoma Cruzi: Evaluation of Their Immunogenic Properties Using a Bioinformatics Approach
por: Diaz-Hernandez, Alejandro, et al.
Publicado: (2022) -
Experimental Vaccines against Chagas Disease: A Journey through History
por: Rodríguez-Morales, Olivia, et al.
Publicado: (2015) -
Recombinant Enolase of Trypanosoma cruzi as a Novel Vaccine Candidate against Chagas Disease in a Mouse Model of Acute Infection
por: Arce-Fonseca, Minerva, et al.
Publicado: (2018) -
Effectiveness of Nitazoxanide and Electrolyzed Oxiding Water in Treating Chagas Disease in a Canine Model
por: Rodríguez-Morales, Olivia, et al.
Publicado: (2023) -
Prophylactic and therapeutic DNA vaccines against Chagas disease
por: Arce-Fonseca, Minerva, et al.
Publicado: (2015)